Show us a sign: the search for "game changing" prostate cancer biomarkers

Affiliations

Comment

David Quinn et al. Lancet Oncol. 2011 Mar.

. 2011 Mar;12(3):204-6.

doi: 10.1016/S1470-2045(11)70003-1.

¹ University of Southern California, Kenneth J Norris Comprehensive Cancer Center, Los Angeles, CA, USA. diquinn@usc.edu

No abstract available

Comment on

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.
Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE, Mesher D, Speights VO, Stankiewicz E, Foster CS, Møller H, Scardino P, Warren JD, Park J, Younus A, Flake DD 2nd, Wagner S, Gutin A, Lanchbury JS, Stone S; Transatlantic Prostate Group. Cuzick J, et al. Lancet Oncol. 2011 Mar;12(3):245-55. doi: 10.1016/S1470-2045(10)70295-3. Lancet Oncol. 2011. PMID: 21310658 Free PMC article.